A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study

Y. Chiu, C. Tang, S. Hung, Y. Yang, C. Fang, H. Lin

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

1 results
- Title
- Start date(ascending)

A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
Chiu, Y. (Contributor), Tang, C. (Contributor), Hung, S. (Contributor), Yang, Y. (Contributor), Fang, C. (Contributor) & Lin, H. (Contributor), Unknown Publisher, May 4 2017
DOI: 10.6084/m9.figshare.4047471.v1, https://tandf.figshare.com/articles/journal_contribution/A_real-world_risk_analysis_of_biological_treatment_adalimumab_and_etanercept_in_a_country_with_a_high_prevalence_of_tuberculosis_and_chronic_liver_disease_a_nationwide_population-based_study/4047471/1
Dataset